Apyx Medical Corporation (APYX)
USD 1.0
(-13.79%)
USD 1.0
(-13.79%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -5.15 Million USD | 45.18% |
| 2022 | -9.39 Million USD | 69.26% |
| 2021 | -30.56 Million USD | 25.88% |
| 2020 | -41.23 Million USD | 28.5% |
| 2019 | -57.67 Million USD | -253.3% |
| 2018 | -16.32 Million USD | -129.46% |
| 2017 | -7.11 Million USD | 37.49% |
| 2016 | -11.38 Million USD | -34.04% |
| 2015 | -8.49 Million USD | -265.88% |
| 2014 | -2.32 Million USD | 50.27% |
| 2013 | -4.66 Million USD | -528.13% |
| 2012 | -743 Thousand USD | -11.9% |
| 2011 | -664 Thousand USD | -437.06% |
| 2010 | 197 Thousand USD | -93.3% |
| 2009 | 2.93 Million USD | 104.68% |
| 2008 | 1.43 Million USD | 140.61% |
| 2007 | -3.53 Million USD | -26.65% |
| 2006 | -2.79 Million USD | -194.73% |
| 2005 | -946.93 Thousand USD | 50.55% |
| 2004 | -1.91 Million USD | -1853.42% |
| 2003 | 109.2 Thousand USD | -81.48% |
| 2002 | 589.59 Thousand USD | 527.52% |
| 2001 | 93.95 Thousand USD | -68.07% |
| 2000 | 294.26 Thousand USD | 18.42% |
| 1999 | 248.49 Thousand USD | -17.65% |
| 1998 | 301.74 Thousand USD | -63.67% |
| 1997 | 830.62 Thousand USD | 47.17% |
| 1996 | 564.4 Thousand USD | -12.55% |
| 1995 | 645.4 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 6.02 Million USD | 348.47% |
| 2024 Q1 | 1.34 Million USD | 126.07% |
| 2023 Q2 | -4.06 Million USD | 39.71% |
| 2023 Q4 | -5.15 Million USD | 33.49% |
| 2023 Q1 | -6.74 Million USD | 28.22% |
| 2023 FY | -5.15 Million USD | 45.18% |
| 2023 Q3 | -7.74 Million USD | -90.48% |
| 2022 Q1 | -26.01 Million USD | 14.88% |
| 2022 Q2 | -19.26 Million USD | 25.96% |
| 2022 Q3 | -14.01 Million USD | 27.22% |
| 2022 Q4 | -9.39 Million USD | 32.98% |
| 2022 FY | -9.39 Million USD | 69.26% |
| 2021 Q4 | -30.56 Million USD | -0.2% |
| 2021 FY | -30.56 Million USD | 25.88% |
| 2021 Q1 | -38.98 Million USD | 5.48% |
| 2021 Q2 | -34.17 Million USD | 12.32% |
| 2021 Q3 | -30.5 Million USD | 10.76% |
| 2020 Q1 | -50.33 Million USD | 12.73% |
| 2020 Q2 | -45.04 Million USD | 10.51% |
| 2020 Q3 | -42.51 Million USD | 5.63% |
| 2020 Q4 | -41.23 Million USD | 2.99% |
| 2020 FY | -41.23 Million USD | 28.5% |
| 2019 FY | -57.67 Million USD | -253.3% |
| 2019 Q4 | -57.67 Million USD | 5.67% |
| 2019 Q3 | -61.14 Million USD | 8.68% |
| 2019 Q2 | -66.95 Million USD | -107.93% |
| 2019 Q1 | -32.2 Million USD | -97.23% |
| 2018 Q1 | -5.92 Million USD | 16.7% |
| 2018 FY | -16.32 Million USD | -129.46% |
| 2018 Q4 | -16.32 Million USD | 59.71% |
| 2018 Q3 | -40.52 Million USD | -685.18% |
| 2018 Q2 | -5.16 Million USD | 12.92% |
| 2017 Q2 | -7.33 Million USD | 13.61% |
| 2017 Q3 | -6.51 Million USD | 11.19% |
| 2017 Q4 | -7.11 Million USD | -9.18% |
| 2017 FY | -7.11 Million USD | 37.49% |
| 2017 Q1 | -8.49 Million USD | 25.38% |
| 2016 FY | -11.38 Million USD | -34.04% |
| 2016 Q1 | -6.2 Million USD | 26.95% |
| 2016 Q2 | -6.13 Million USD | 1.16% |
| 2016 Q3 | -6.19 Million USD | -1.06% |
| 2016 Q4 | -11.38 Million USD | -83.72% |
| 2015 FY | -8.49 Million USD | -265.88% |
| 2015 Q3 | -9.96 Million USD | 7.65% |
| 2015 Q2 | -10.79 Million USD | 10.37% |
| 2015 Q1 | -12.04 Million USD | -418.91% |
| 2015 Q4 | -8.49 Million USD | 14.82% |
| 2014 Q4 | -2.32 Million USD | 12.88% |
| 2014 Q3 | -2.66 Million USD | -30.4% |
| 2014 Q2 | -2.04 Million USD | 8.14% |
| 2014 FY | -2.32 Million USD | 50.27% |
| 2014 Q1 | -2.22 Million USD | 52.35% |
| 2013 Q1 | -377 Thousand USD | 49.26% |
| 2013 Q3 | 815 Thousand USD | 2.77% |
| 2013 Q4 | -4.66 Million USD | -672.64% |
| 2013 FY | -4.66 Million USD | -528.13% |
| 2013 Q2 | 793 Thousand USD | 310.34% |
| 2012 Q4 | -743 Thousand USD | -1.23% |
| 2012 FY | -743 Thousand USD | -11.9% |
| 2012 Q1 | -184 Thousand USD | 72.29% |
| 2012 Q2 | -4.47 Million USD | -2333.15% |
| 2012 Q3 | -734 Thousand USD | 83.61% |
| 2011 Q2 | -1.93 Million USD | -203.3% |
| 2011 FY | -664 Thousand USD | -437.06% |
| 2011 Q4 | -664 Thousand USD | 60.02% |
| 2011 Q3 | -1.66 Million USD | 14.03% |
| 2011 Q1 | -637 Thousand USD | -423.35% |
| 2010 Q1 | 2.42 Million USD | -17.63% |
| 2010 FY | 197 Thousand USD | -93.3% |
| 2010 Q3 | 1.12 Million USD | 155.48% |
| 2010 Q4 | 197 Thousand USD | -82.48% |
| 2010 Q2 | 440.08 Thousand USD | -81.82% |
| 2009 Q2 | 2.09 Million USD | 22.97% |
| 2009 FY | 2.93 Million USD | 104.68% |
| 2009 Q3 | 2.25 Million USD | 7.63% |
| 2009 Q4 | 2.93 Million USD | 30.58% |
| 2009 Q1 | 1.7 Million USD | 18.43% |
| 2008 Q2 | -3.77 Million USD | -7.34% |
| 2008 Q4 | 1.43 Million USD | 216.34% |
| 2008 FY | 1.43 Million USD | 140.61% |
| 2008 Q1 | -3.52 Million USD | 0.42% |
| 2008 Q3 | -1.23 Million USD | 67.34% |
| 2007 Q1 | -2.72 Million USD | 2.37% |
| 2007 FY | -3.53 Million USD | -26.65% |
| 2007 Q2 | -2.1 Million USD | 22.88% |
| 2007 Q3 | -2.23 Million USD | -6.48% |
| 2007 Q4 | -3.53 Million USD | -57.97% |
| 2006 Q1 | -1.26 Million USD | -33.36% |
| 2006 Q2 | -1.7 Million USD | -35.18% |
| 2006 Q3 | -2.1 Million USD | -23.38% |
| 2006 FY | -2.79 Million USD | -194.73% |
| 2006 Q4 | -2.79 Million USD | -32.51% |
| 2005 Q3 | -910.61 Thousand USD | -25.39% |
| 2005 Q4 | -946.93 Thousand USD | -3.99% |
| 2005 Q2 | -726.21 Thousand USD | 65.58% |
| 2005 Q1 | -2.11 Million USD | -10.2% |
| 2005 FY | -946.93 Thousand USD | 50.55% |
| 2004 Q2 | -846.65 Thousand USD | -132.93% |
| 2004 Q1 | -363.47 Thousand USD | -432.85% |
| 2004 Q4 | -1.91 Million USD | -10.08% |
| 2004 Q3 | -1.73 Million USD | -105.45% |
| 2004 FY | -1.91 Million USD | -1853.42% |
| 2003 FY | 109.2 Thousand USD | -81.48% |
| 2003 Q1 | 768.27 Thousand USD | 30.31% |
| 2003 Q4 | 109.2 Thousand USD | 177.95% |
| 2003 Q3 | -140.09 Thousand USD | 58.86% |
| 2003 Q2 | -340.49 Thousand USD | -144.32% |
| 2002 Q2 | 215.6 Thousand USD | 5712.94% |
| 2002 Q4 | 589.59 Thousand USD | 633.32% |
| 2002 FY | 589.59 Thousand USD | 527.52% |
| 2002 Q3 | 80.4 Thousand USD | -62.71% |
| 2002 Q1 | 3709.00 USD | -96.05% |
| 2001 FY | 93.95 Thousand USD | -68.07% |
| 2001 Q1 | 271.81 Thousand USD | -7.63% |
| 2001 Q2 | 429.55 Thousand USD | 58.04% |
| 2001 Q3 | 402.7 Thousand USD | -6.25% |
| 2001 Q4 | 93.95 Thousand USD | -76.67% |
| 2000 Q4 | 294.26 Thousand USD | 73.28% |
| 2000 Q1 | -4854.00 USD | -102.43% |
| 2000 FY | 294.26 Thousand USD | 18.42% |
| 2000 Q3 | 169.82 Thousand USD | 54.94% |
| 2000 Q2 | 109.6 Thousand USD | 2358.03% |
| 1999 FY | 248.49 Thousand USD | -17.65% |
| 1999 Q1 | 200 Thousand USD | -33.33% |
| 1999 Q2 | - USD | -100.0% |
| 1999 Q3 | -500 Thousand USD | 0.0% |
| 1999 Q4 | 200 Thousand USD | 140.0% |
| 1998 Q1 | 700 Thousand USD | -22.22% |
| 1998 Q2 | 3.7 Million USD | 428.57% |
| 1998 Q3 | 200 Thousand USD | -94.59% |
| 1998 Q4 | 300 Thousand USD | 50.0% |
| 1998 FY | 301.74 Thousand USD | -63.67% |
| 1997 Q2 | 900 Thousand USD | 12.5% |
| 1997 Q1 | 800 Thousand USD | 33.33% |
| 1997 Q4 | 900 Thousand USD | 0.0% |
| 1997 FY | 830.62 Thousand USD | 47.17% |
| 1997 Q3 | 900 Thousand USD | 0.0% |
| 1996 Q2 | 600 Thousand USD | -14.29% |
| 1996 FY | 564.4 Thousand USD | -12.55% |
| 1996 Q3 | 600 Thousand USD | 0.0% |
| 1996 Q1 | 700 Thousand USD | 16.67% |
| 1996 Q4 | 600 Thousand USD | 0.0% |
| 1995 Q4 | 600 Thousand USD | 0.0% |
| 1995 FY | 645.4 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 119.02% |
| BrainsWay Ltd. | -10.32 Million USD | 50.087% |
| Cerus Corporation | 84.35 Million USD | 106.107% |
| Envoy Medical, Inc. | -3.81 Million USD | -35.055% |
| electroCore, Inc. | -9.95 Million USD | 48.257% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | -0.507% |
| IceCure Medical Ltd | -9.93 Million USD | 48.148% |
| Inogen, Inc. | -103.56 Million USD | 95.027% |
| OrthoPediatrics Corp. | -9.26 Million USD | 44.416% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -41.472% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 60.67% |
| MaxCyte, Inc. | -27.76 Million USD | 81.447% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | -0.251% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -794.633% |
| Orthofix Medical Inc. | 96.44 Million USD | 105.341% |
| PAVmed Inc | 29.08 Million USD | 117.71% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 69.591% |
| RxSight, Inc. | -6.68 Million USD | 22.889% |
| Sight Sciences, Inc. | -102.71 Million USD | 94.985% |
| SI-BONE, Inc. | 5.72 Million USD | 190.037% |
| TELA Bio, Inc. | -3.94 Million USD | -30.438% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 108.986% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 1563.352% |
| Acutus Medical, Inc. | 12.27 Million USD | 141.95% |
| Talis Biomedical Corporation | -57.06 Million USD | 90.973% |
| Spectral AI, Inc. | -3.5 Million USD | -47.129% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 89.275% |
| CVRx, Inc. | -59.95 Million USD | 91.409% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 359.608% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 503.166% |
| Bioventus Inc. | 372.51 Million USD | 101.383% |
| Venus Concept Inc. | 74.3 Million USD | 106.933% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 49.411% |
| LivaNova PLC | 62.53 Million USD | 108.237% |
| 908 Devices Inc. | -115.09 Million USD | 95.525% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 101.606% |
| Nemaura Medical Inc. | 9.92 Million USD | 151.899% |
| NeuroPace, Inc. | 54.33 Million USD | 109.48% |
| LENSAR, Inc. | -18.31 Million USD | 71.871% |
| Cutera, Inc. | 288.3 Million USD | 101.787% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 168.543% |
| BioSig Technologies, Inc. | 262 Thousand USD | 2066.031% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 88.248% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 44.005% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.367% |
| Axonics, Inc. | -77.19 Million USD | 93.327% |
| Outset Medical, Inc. | 67.67 Million USD | 107.611% |
| IRIDEX Corporation | -4.28 Million USD | -20.126% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 97.106% |
| IRadimed Corporation | -47.71 Million USD | 89.206% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -70.225% |
| INVO Bioscience, Inc. | 8.45 Million USD | 160.95% |
| Telesis Bio, Inc. | 32.63 Million USD | 115.784% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -105.864% |
| Varex Imaging Corporation | 316.9 Million USD | 101.625% |
| Quipt Home Medical Corp. | 81.73 Million USD | 106.302% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -85.155% |
| Pulmonx Corporation | -42.36 Million USD | 87.84% |
| Dynatronics Corporation | 6.2 Million USD | 183.027% |
| Modular Medical, Inc. | -8.04 Million USD | 35.949% |
| ReShape Lifesciences Inc. | -4.29 Million USD | -19.874% |
| Semler Scientific, Inc. | -57.13 Million USD | 90.984% |
| InMode Ltd. | -135.39 Million USD | 96.196% |
| Bruker Corporation | 891.3 Million USD | 100.578% |
| Cytosorbents Corporation | 4.18 Million USD | 223.17% |
| DexCom, Inc. | 2.02 Billion USD | 100.254% |
| Align Technology, Inc. | -840.47 Million USD | 99.387% |
| Viveve Medical, Inc. | -13.81 Million USD | 62.709% |
| ZimVie Inc. | 450.41 Million USD | 101.144% |
| Movano Inc. | -5.86 Million USD | 12.189% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 96.169% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -794.633% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 359.608% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 101.444% |
| Profound Medical Corp. | -18.17 Million USD | 71.664% |
| Insulet Corporation | 798.1 Million USD | 100.645% |
| enVVeno Medical Corporation | -2.21 Million USD | -132.236% |
| Surmodics, Inc. | -12.01 Million USD | 57.125% |
| iCAD, Inc. | -21.2 Million USD | 75.713% |
| Nuwellis, Inc. | -2.81 Million USD | -82.724% |
| Biotricity, Inc. | 23.09 Million USD | 122.306% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 105.5% |
| Aethlon Medical, Inc. | -4.5 Million USD | -14.424% |
| InspireMD, Inc. | -8.04 Million USD | 35.973% |
| PAVmed Inc. | 29.08 Million USD | 117.71% |
| BIOLASE, Inc. | 11.34 Million USD | 145.407% |
| Beyond Air, Inc. | 6.22 Million USD | 182.694% |
| FONAR Corporation | -14.66 Million USD | 64.876% |
| AxoGen, Inc. | 32.26 Million USD | 115.964% |
| Vivani Medical, Inc. | 42 Thousand USD | 12364.286% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 51.67% |
| Inari Medical, Inc. | -7.16 Million USD | 28.069% |
| UFP Technologies, Inc. | 40.77 Million USD | 112.633% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 267.86% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | -7.958% |
| Tenon Medical, Inc. | -1.25 Million USD | -310.438% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 32.277% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 56.81% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.232% |
| Sintx Technologies, Inc. | 905 Thousand USD | 669.171% |
| NanoVibronix, Inc. | -3.27 Million USD | -57.138% |
| Quanterix Corporation | -132.95 Million USD | 96.126% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -85.155% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 76.968% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 100.683% |
| TransMedics Group, Inc. | 121.13 Million USD | 104.252% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 80.325% |
| NeuroMetrix, Inc. | -1.49 Million USD | -245.457% |
| Hyperfine, Inc. | -75.61 Million USD | 93.188% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 103.385% |
| Biomerica, Inc. | -3.38 Million USD | -52.171% |
| Bone Biologics Corporation | -3.02 Million USD | -70.193% |
| AVITA Medical, Inc. | -26.23 Million USD | 80.363% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -180.188% |
| Silk Road Medical, Inc | 64.42 Million USD | 107.996% |